POLMED S.A. secured a strategic investment from a consortium of investors, including INVL Private Equity Fund II, IFC, and Accession Capital Partners, aimed at enhancing its market presence in Poland's expanding healthcare sector.

Information on the Target

POLMED S.A. is a leading private healthcare operator in Poland, consistently expanding its scale and service offerings since its inception in 1999. The company has recently entered into a partnership with a consortium of investors, including INVL Private Equity Fund II, International Finance Corporation (IFC), and Accession Capital Partners, to support its next phase of growth. POLMED generates over €100 million in revenues and provides a comprehensive range of healthcare services—from outpatient care to diagnostic imaging and both home and stationary rehabilitation. With a network of over 4,000 medical partners and a dedicated workforce of 2,000 specialists, POLMED caters to over 4 million patients annually, including more than 3,500 corporate clients.

Industry Overview in Poland

The healthcare industry in Poland has seen significant growth over recent years, propelled by increasing investment and demand for quality medical services. The sector is evolving with a greater emphasis on private healthcare, which is becoming increasingly accessible to the general population. Government reforms and a rising awareness of health issues are further influencing this shift, leading to a more competitive landscape.

Moreover, Poland's healthcare market benefits from EU funding aimed at improving public healthcare systems and incentivizing private investments. With